Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001209191-23-000948

Options or other derivatives

  • Chief Medical Officer acquired 135,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Janku Filip Chief Medical Officer 2023-01-03 Grant or award · Stock Option (Right to Buy) +135,000 135,000 D
Loading xslF345X03/doc4.xml…